Lipopolysaccharide-binding Protein is Associated with Arterial Stiffness in Patients with Type 2 Diabetes: a Cross-sectional Study

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2017 May 11

PMID 28486964

Citations 31

Authors

Takeshi Sakura

Tomoaki Morioka

Atsushi Shioi

Yoshinori Kakutani

Yuya Miki

Yuko Yamazaki

Koka Motoyama

Katsuhito Mori

Shinya Fukumoto

Tetsuo Shoji

Masanori Emoto

Masaaki Inaba

Affiliations

Soon will be listed here.

Abstract

Background: Lipopolysaccharide (LPS)-binding protein (LBP) is an acute-phase reactant that mediates immune responses triggered by LPS. Recent evidence indicates the association of circulating LBP levels with obesity, diabetes, and cardiovascular diseases. In this study, we aimed to investigate the relationship between serum LBP levels and arterial stiffness in patients with type 2 diabetes.

Methods: A total of 196 patients with type 2 diabetes, including 101 men and 95 women, were enrolled in this cross-sectional study. Fasting serum LBP levels were determined by enzyme-linked immunosorbent assay. Arterial stiffness was assessed by measuring the aortic pulse wave velocity (PWV).

Results: The mean values of serum LBP and aortic PWV were 18.2 μg/mL and 1194 cm/s, respectively. Serum LBP levels were positively correlated with body mass index, triglycerides, high-sensitivity C-reactive protein, and insulin resistance index and were negatively correlated with high-density lipoprotein cholesterol. They were, however, not significantly correlated with aortic PWV in univariate analyses. Multivariate analysis revealed that serum LBP levels were independently and positively associated with aortic PWV (β = 0.135, p = 0.026) after adjusting for age, sex, body mass index, albumin, high-sensitivity C-reactive protein, and other cardiovascular risk factors. Further analyses revealed that the impact of serum LBP levels on aortic PWV was modified by sex, and the association between serum LBP levels and aortic PWV was found to be significant only in men.

Conclusions: Serum LBP levels are associated with arterial stiffness, independent of obesity and traditional cardiovascular risk factors, especially in men with type 2 diabetes. This study indicates a potential role of the LPS/LBP-induced innate immunity in the development and progression of arterial stiffness in type 2 diabetes.

Citing Articles

Comparative Analysis of Plasma Protein Dynamics in Women with ST-Elevation Myocardial Infarction and Takotsubo Syndrome.

Hussain S, Jha S, Berger E, Molander L, Sevastianova V, Sheybani Z Cells. 2024; 13(21.

PMID: 39513871 PMC: 11545104. DOI: 10.3390/cells13211764.

Comprehensive serum proteomics profiles and potential protein biomarkers for the early detection of advanced adenoma and colorectal cancer.

Tan C, Qin G, Wang Q, Li K, Zhou Y, Yao S World J Gastrointest Oncol. 2024; 16(7):2971-2987.

PMID: 39072170 PMC: 11271786. DOI: 10.4251/wjgo.v16.i7.2971.

Effects of Polymannuronic Acid on the Intestinal Microbiota in Mice after Long-Term Intragastric Administration.

Zhang E, Wei Q, Li X, Song S Mar Drugs. 2024; 22(3).

PMID: 38535466 PMC: 10972068. DOI: 10.3390/md22030125.

CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice.

Kim W, Kil B, Lee C, Kim T, Han G, Choi Y Gut Microbes. 2024; 16(1):2319889.

PMID: 38391178 PMC: 10896159. DOI: 10.1080/19490976.2024.2319889.

The gut microbiome as a modulator of arterial function and age-related arterial dysfunction.

Longtine A, Greenberg N, Bernaldo de Quiros Y, Brunt V Am J Physiol Heart Circ Physiol. 2024; 326(4):H986-H1005.

PMID: 38363212 PMC: 11279790. DOI: 10.1152/ajpheart.00764.2023.

References

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982-92. DOI: 10.1053/j.ajkd.2008.12.034. View

Kimoto E, Shoji T, Shinohara K, Inaba M, Okuno Y, Miki T . Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes. 2003; 52(2):448-52. DOI: 10.2337/diabetes.52.2.448. View

Morioka T, Emoto M, Yamazaki Y, Kawano N, Imamura S, Numaguchi R . Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes. Cardiovasc Diabetol. 2014; 13:10. PMC: 3893526. DOI: 10.1186/1475-2840-13-10. View

Morigami H, Morioka T, Yamazaki Y, Imamura S, Numaguchi R, Asada M . Visceral Adiposity is Preferentially Associated with Vascular Stiffness Rather than Thickness in Men with Type 2 Diabetes. J Atheroscler Thromb. 2016; 23(9):1067-79. PMC: 5090813. DOI: 10.5551/jat.33399. View

Lepper P, Schumann C, Triantafilou K, Rasche F, Schuster T, Frank H . Association of lipopolysaccharide-binding protein and coronary artery disease in men. J Am Coll Cardiol. 2007; 50(1):25-31. DOI: 10.1016/j.jacc.2007.02.070. View

Ramos L, Shintani A, Ikizler T, Himmelfarb J . Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol. 2008; 19(3):593-9. PMC: 2391046. DOI: 10.1681/ASN.2007030355. View

. Standards of medical care in diabetes--2014. Diabetes Care. 2013; 37 Suppl 1:S14-80. DOI: 10.2337/dc14-S014. View

Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F . Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One. 2013; 8(1):e54600. PMC: 3551812. DOI: 10.1371/journal.pone.0054600. View

Moreno-Navarrete J, Ortega F, Serino M, Luche E, Waget A, Pardo G . Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond). 2011; 36(11):1442-9. DOI: 10.1038/ijo.2011.256. View

10.

Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-34. DOI: 10.1056/NEJM199807233390404. View

11.

Tilves C, Zmuda J, Kuipers A, Nestlerode C, Evans R, Bunker C . Association of Lipopolysaccharide-Binding Protein With Aging-Related Adiposity Change and Prediabetes Among African Ancestry Men. Diabetes Care. 2016; 39(3):385-91. PMC: 4764043. DOI: 10.2337/dc15-1777. View

12.

Paolillo R, Iovene M, Romano Carratelli C, Rizzo A . Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae. Int J Immunopathol Pharmacol. 2012; 25(2):377-86. DOI: 10.1177/039463201202500207. View

13.

Moreno-Navarrete J, Escote X, Ortega F, Serino M, Campbell M, Michalski M . A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia. 2013; 56(11):2524-37. DOI: 10.1007/s00125-013-3015-9. View

14.

Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H . Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol. 2001; 12(10):2117-2124. DOI: 10.1681/ASN.V12102117. View

15.

Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso M, Recio-Rodriguez J, Fernando R, Marti R . Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol. 2016; 15(1):148. PMC: 5078926. DOI: 10.1186/s12933-016-0465-7. View

16.

Liu X, Lu L, Yao P, Ma Y, Wang F, Jin Q . Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese. Diabetologia. 2014; 57(9):1834-41. DOI: 10.1007/s00125-014-3288-7. View

17.

Li H, Xu H, Sun B . Lipopolysaccharide regulates MMP-9 expression through TLR4/NF-κB signaling in human arterial smooth muscle cells. Mol Med Rep. 2012; 6(4):774-8. DOI: 10.3892/mmr.2012.1010. View

18.

Stehouwer C, Henry R, Ferreira I . Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008; 51(4):527-39. DOI: 10.1007/s00125-007-0918-3. View

19.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

20.

Wiedermann C, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F . Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol. 1999; 34(7):1975-81. DOI: 10.1016/s0735-1097(99)00448-9. View